Patents by Inventor Leon WAN

Leon WAN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20260325510
    Abstract: The present disclosure relates to combinations comprising an ATR inhibitor and a PARP inhibitor and optionally further comprising an additional pharmaceutically active agent. Also provided are certain methods of treatment, e.g., a method for treating cancer such as ovarian cancer, with a combination comprising an effective amount of an ATR inhibitor and an effective amount of a PARP inhibitor and optionally further comprising an additional pharmaceutically active agent. In particular, a combination comprising a liposomal composition of an ATR inhibitor and a liposomal composition of a PARP inhibitor is disclosed herein.
    Type: Application
    Filed: July 12, 2024
    Publication date: October 22, 2026
    Inventors: Leon WAN, Shyam GARG, Robert HAUPTSCHEIN, Philippe LEGROS, Paul TARDI, Lucy WANG, Christine ALLEN
  • Publication number: 20260325511
    Abstract: The present disclosure generally relates to liposomal compositions comprising an ATR inhibitor and uses thereof for treating various diseases and disorders. In one aspect, the use relates to methods of treating cancer, such as pancreatic cancer, breast cancer, and lung cancer.
    Type: Application
    Filed: July 12, 2024
    Publication date: October 22, 2026
    Inventors: Leon WAN, Shyam GARG, Robert HAUPTSCHEIN, Philippe LEGROS, Paul TARDI
  • Patent number: 12734181
    Abstract: Provided herein are methods of purifying liposomal formulations by washing with acidic aqueous solutions.
    Type: Grant
    Filed: July 15, 2022
    Date of Patent: September 15, 2026
    Assignee: Jazz Pharmaceuticals Therapeutics, Inc.
    Inventors: Paul Tardi, Leon Wan, Shyam Madhusudan Garg, Jun Gao, Philippe Legros
  • Publication number: 20260108534
    Abstract: Provided herein are liposomes comprising B-cell lymphoma (Bcl) protein inhibitors, compositions comprising such liposomes, and methods using such formulations for treating hyperproliferative disorders.
    Type: Application
    Filed: September 30, 2025
    Publication date: April 23, 2026
    Inventors: Paul TARDI, Leon WAN, Shyam Madhusudan GARG, Jun GAO, Philippe LEGROS
  • Patent number: 12447163
    Abstract: Provided herein are liposomes comprising B-cell lymphoma (Bcl) protein inhibitors, compositions comprising such liposomes, and methods using such formulations for treating hyperproliferative disorders.
    Type: Grant
    Filed: July 15, 2022
    Date of Patent: October 21, 2025
    Assignee: Jazz Pharmaceuticals Therapeutics, Inc.
    Inventors: Paul Tardi, Leon Wan, Shyam Madhusudan Garg, Jun Gao, Philippe Legros
  • Publication number: 20240366519
    Abstract: Nanoparticle compositions described herein comprise combinations of prodrugs of therapeutic agents that achieve enhanced therapeutic effects as compared to those observed when combinations of free forms of these therapeutic agents are administered.
    Type: Application
    Filed: July 15, 2022
    Publication date: November 7, 2024
    Applicant: Celator Pharmaceuticals, Inc.
    Inventors: Leon WAN, Winnie LUI, Paul TARDI, Lawrence MAYER
  • Publication number: 20240350411
    Abstract: Provided herein are methods of purifying liposomal formulations by washing with acidic aqueous solutions.
    Type: Application
    Filed: July 15, 2022
    Publication date: October 24, 2024
    Inventors: Paul TARDI, Leon WAN, Shyam Madhusudan GARG, Jun GAO, Philippe LEGROS
  • Publication number: 20230059528
    Abstract: Provided herein are liposomes comprising B-cell lymphoma (Bcl) protein inhibitors, compositions comprising such liposomes, and methods using such formulations for treating hyperproliferative disorders.
    Type: Application
    Filed: July 15, 2022
    Publication date: February 23, 2023
    Applicant: Celator Pharmaceuticals, Inc.
    Inventors: Paul TARDI, Leon Wan, Shyam Madhusudan Garg, Jun Gao, Philippe Legros
  • Patent number: 11413253
    Abstract: Nanoparticle compositions described herein comprise combinations of prodrugs of therapeutic agents that achieve enhanced therapeutic effects as compared to those observed when combinations of free forms of these therapeutic agents are administered.
    Type: Grant
    Filed: September 4, 2020
    Date of Patent: August 16, 2022
    Assignee: Celator Pharmaceuticals, Inc.
    Inventors: Leon Wan, Winnie Lui, Paul Tardi, Lawrence Mayer
  • Publication number: 20210052508
    Abstract: Nanoparticle compositions described herein comprise combinations of prodrugs of therapeutic agents that achieve enhanced therapeutic effects as compared to those observed when combinations of free forms of these therapeutic agents are administered.
    Type: Application
    Filed: September 4, 2020
    Publication date: February 25, 2021
    Applicant: Celator Pharmaceuticals, Inc.
    Inventors: Leon WAN, Winnie LUI, Paul TARDI, Lawrence MAYER
  • Publication number: 20190209484
    Abstract: Nanoparticle compositions described herein comprise combinations of prodrugs of therapeutic agents that achieve enhanced therapeutic effects as compared to those observed when combinations of free forms of these therapeutic agents are administered.
    Type: Application
    Filed: March 15, 2019
    Publication date: July 11, 2019
    Applicant: CELATOR PHARMACEUTICALS, INC.
    Inventors: Leon WAN, Winnie LUI, Paul TARDI, Lawrence MAYER
  • Patent number: 10285951
    Abstract: Nanoparticle compositions described herein comprise combinations of prodrugs of therapeutic agents that achieve enhanced therapeutic effects as compared to those observed when combinations of free forms of these therapeutic agents are administered.
    Type: Grant
    Filed: July 14, 2016
    Date of Patent: May 14, 2019
    Assignee: CELATOR PHARMACEUTICALS, INC.
    Inventors: Leon Wan, Winnie Lui, Paul Tardi, Lawrence Mayer
  • Publication number: 20180207104
    Abstract: Nanopaiticle compositions described herein comprise combinations of prodrugs of therapeutic agents that achieve enhanced therapeutic effects as compared to those observed when combinations of free forms of these therapeutic agents are administered.
    Type: Application
    Filed: July 14, 2016
    Publication date: July 26, 2018
    Applicant: CELATOR PHARMACEUTICALS, INC.
    Inventors: Leon WAN, Winnie LUI, Paul TARDI, Lawrence MAYER